Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health is a promising investment for its strong performance and potential for future growth. However, it also faces risks such as competition and user engagement. Investors should monitor the company's revenue and operating margins as well as their ability to retain and engage users. Additionally, their current valuation may be inflated compared to their peers which should also be considered before making a decision to invest. Overall, Hinge Health's innovative technology and strategic partnerships make it a solid bet for long-term growth in the virtual physical therapy market.

Bears say

Hinge Health is experiencing strong growth in monthly active users and downloads, however this may not translate into consistent and sustained engagement with the platform. Additionally, the company's primary competitor is facing challenges in retaining prospects and Hinge Health may also face similar difficulties. While the company has raised its financial guidance, the underlying factors driving this raise are not sustainable and may be due to short-term momentum rather than long-term growth potential. Overall, there are concerns about the company's ability to achieve widespread and sustained adoption in the increasingly competitive market for digital healthcare solutions.

HNGE has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 17 analysts, HNGE has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $62.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $62.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.